<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>The New England Journal of Medicine: Search Results in Pediatrics</title>
        <description>The New England Journal of Medicine (NEJM) RSS feed -- Search Results in Pediatrics. NEJM (https://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.</description>
        <link>https://www.nejm.org/action/showPodcastsFeeds</link>
        <generator>NEJM Group</generator>
        <lastBuildDate>Thu, 19 Nov 2026 07:11:24 GMT</lastBuildDate>
        <copyright>2026 NEJM Group</copyright>
        <language>en-us</language>
        <ttl>1440</ttl>
        <atom:link href="https://onesearch-rss.nejmgroup-production.org/specialty/pediatrics" rel="self" type="application/rss+xml"/>
        <item>
            <title>Revertant Autograft Replacement in Recessive Dystrophic Epidermolysis Bullosa</title>
            <description>Two adolescents with epidermolysis bullosa received autografts from revertant skin, which provided durable epidermal replacement over approximately 95% of the body-surface area in one patient and 50% in the other.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMc2517823?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMc2517823</guid>
            <dc:creator>Akiharu Kubo, Hisato Suzuki, Noriko Ono, Sonoko Saito, Satomi Aoki, Yuki Ogawa, Hiroto Horikawa, Yoshio Nakamura, Takeru Funakoshi, Tomoyo Tanaka, Masukazu Inoie, Kenjiro Kosaki, Masayuki Amagai</dc:creator>
            <dc:date>2026-11-19</dc:date>
            <dc:title>Revertant Autograft Replacement in Recessive Dystrophic Epidermolysis Bullosa</dc:title>
        </item>
        <item>
            <title>Semaglutide for the Treatment of Obesity in Children 6 to &lt;12 Years of Age</title>
            <description>In a phase 3, double-blind, randomized trial involving 167 children (6 to &lt;12 years of age) with obesity, treatment with semaglutide resulted in a significantly greater reduction in BMI than placebo.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMoa2604058?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMoa2604058</guid>
            <dc:creator>Ania M. Jastreboff, Nina M. Harder-Lauridsen, Michelle Van Name, Antje Körner, Aaron S. Kelly, Daniel Weghuber, Jens-Christian Holm, Christine Frithioff-Bøjsøe, Shilpa Middolu, Tina Buch, Martin Wabitsch, the STEP Young Investigators*</dc:creator>
            <dc:date>2026-11-16</dc:date>
            <dc:title>Semaglutide for the Treatment of Obesity in Children 6 to &amp;lt;12 Years of Age</dc:title>
        </item>
        <item>
            <title>Preventing Malaria Infections and Moving toward Malaria Elimination</title>
            <description>Resistance threatens existing preventive tools for malaria. Next-generation bed nets are now available, and biologic and genetic approaches show promise. New vaccines offer protection for young children.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMra2508563?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMra2508563</guid>
            <dc:creator>Andre Marie Tchouatieu, Timothy N.C. Wells, Jane Achan</dc:creator>
            <dc:date>2026-11-12</dc:date>
            <dc:title>Preventing Malaria Infections and Moving toward Malaria Elimination</dc:title>
        </item>
        <item>
            <title>When Patients Need an Enemy</title>
            <description>When patients, or the parents of patients, become heavily invested in searching for someone to blame for an illness, it’s useful to ask what the search is doing for them. Its accuracy is rarely the point.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2606011?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2606011</guid>
            <dc:creator>Daniel A. Brenner</dc:creator>
            <dc:date>2026-11-05</dc:date>
            <dc:title>When Patients Need an Enemy</dc:title>
        </item>
        <item>
            <title>Gram-Negative Bacterial Resistance</title>
            <description>The spread of gram-negative antimicrobial resistance is driven by human, environmental, and other factors. The author reviews clinically important pathogens, mechanisms driving resistance, and strategies for treatment.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMra2506114?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMra2506114</guid>
            <dc:creator>Pranita D. Tamma</dc:creator>
            <dc:date>2026-10-29</dc:date>
            <dc:title>Gram-Negative Bacterial Resistance</dc:title>
        </item>
        <item>
            <title>The Future of Health Agency Enforcement Fines</title>
            <description>Agencies have long relied on civil monetary penalties to address violations of health care and public health regulations. But rules governing federal fines are now in flux.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2609972?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2609972</guid>
            <dc:creator>Anjali D. Deshmukh, Joan H. Krause</dc:creator>
            <dc:date>2026-10-29</dc:date>
            <dc:title>The Future of Health Agency Enforcement Fines</dc:title>
        </item>
        <item>
            <title>SLC6A19 Inhibitor Repinatrabit and Phenylalanine Levels in Phenylketonuria</title>
            <description>In this phase 2 trial involving adults with phenylketonuria with baseline phenylalanine (Phe) levels above 600 μmol per liter, repinatrabit, a selective oral inhibitor of human SLC6A19, substantially decreased plasma Phe levels.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMc2514812?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMc2514812</guid>
            <dc:creator>Cary O. Harding, Nicola Longo, Markey McNutt, Rani H. Singh, Andreu Viader, George Vratsanos, Haoling H. Weng, Elaina Jurecki, Fernanda Leal-Pardinas, Wei Li, Guissou Dabiri, John P. Throup, Ania C. Muntau, for the JNT517-101 Trial Investigators Group*</dc:creator>
            <dc:date>2026-10-29</dc:date>
            <dc:title>SLC6A19 Inhibitor Repinatrabit and Phenylalanine Levels in Phenylketonuria</dc:title>
        </item>
        <item>
            <title>Gene Therapy for Phenylketonuria in Adults</title>
            <description>Eight adults with phenylketonuria received infusions of an adeno-associated virus serotype 8 vector carrying PAH cDNA.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMc2518656?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMc2518656</guid>
            <dc:creator>Huan Zhou, Xiaoli Li, Jiaxiang Ding, Hongtao Li, Yue Su, Jingjing Ye, Xiaoyue Li, Dongmei Cheng, Ying Wang, Yuzhou Ding, Jie Si, Lin Zhan, Yunqiu Xie, Yuanyuan Liu, Nan Han, Gang Wang, Yiting Liu, Guang Qu, Lixin Jiang, Jianping Weng</dc:creator>
            <dc:date>2026-10-29</dc:date>
            <dc:title>Gene Therapy for Phenylketonuria in Adults</dc:title>
        </item>
        <item>
            <title>What I See before Anyone Speaks</title>
            <description>Trust is the precondition for informed consent, shared decision making, and any clinical intervention. But public trust in medicine is rapidly eroding, and it can’t be rebuilt in a single policy cycle.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2604584?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2604584</guid>
            <dc:creator>Robert B. Shpiner</dc:creator>
            <dc:date>2026-10-22</dc:date>
            <dc:title>What I See before Anyone Speaks</dc:title>
        </item>
        <item>
            <title>Perspective Roundtable: Examining the Use of Race in Clinical Algorithms</title>
            <description>This video roundtable explores the history, rationale, process, and effects of eliminating the inappropriate and inequitable use of race in clinical algorithms.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2612470?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2612470</guid>
            <dc:creator>Helen Burstin, Felicity T. Enders, Sean Levy, Shazia Siddique, Joseph L. Wright, Debra Malina</dc:creator>
            <dc:date>2026-10-22</dc:date>
            <dc:title>Perspective Roundtable: Examining the Use of Race in Clinical Algorithms</dc:title>
        </item>
        <item>
            <title>Adult Attention Deficit–Hyperactivity Disorder</title>
            <description>This review summarizes the assessment and treatment of adult attention deficit–hyperactivity disorder, with an emphasis on common psychiatric and medical coexisting conditions and combined pharmacologic and psychosocial care.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMcp2516040?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMcp2516040</guid>
            <dc:creator>Jan K. Buitelaar, Jeffrey H. Newcorn</dc:creator>
            <dc:date>2026-10-15</dc:date>
            <dc:title>Adult Attention Deficit–Hyperactivity Disorder</dc:title>
        </item>
        <item>
            <title>Who Counts as Infertile? A Missed Opportunity for Inclusion</title>
            <description>The World Health Organization recently issued its first global guidelines on the prevention, diagnosis, and treatment of infertility, but they pertain only to heterosexual couples.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2603604?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2603604</guid>
            <dc:creator>Paula Amato, I. Glenn Cohen</dc:creator>
            <dc:date>2026-10-15</dc:date>
            <dc:title>Who Counts as Infertile? A Missed Opportunity for Inclusion</dc:title>
        </item>
        <item>
            <title>Integration-Associated Paraspinal Neoplasm after AAV Gene Therapy</title>
            <description>The authors report AAV integration in a paraspinal neoplasm after gene therapy. The integrated sequence retained a CAG promoter–enhancer and activated a developmental transcription factor.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMc2607927?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMc2607927</guid>
            <dc:creator>Josh N. Vo, Yi-Mi Wu, Amer Heider, Xuhong Cao, Rui Wang, Tiffany Pham, Guo Ci Teo, Suresh N. Magge, Hemant Parmar, Rajen Mody, Dan R. Robinson, Arul M. Chinnaiyan</dc:creator>
            <dc:date>2026-10-15</dc:date>
            <dc:title>Integration-Associated Paraspinal Neoplasm after AAV Gene Therapy</dc:title>
        </item>
        <item>
            <title>Case 28-2026: A 19-Year-Old Woman with Fever, Cervical Lymphadenopathy, and Leukopenia</title>
            <description>A 19-year-old woman presented with fever and cervical lymphadenopathy. The white-cell count was 2900 per microliter (reference range, 4000 to 11,000), and the lactate dehydrogenase level was elevated. A diagnosis was made.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMcpc2603182?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMcpc2603182</guid>
            <dc:creator>Ezra M. Cohen, Shohei Fujita, Daniel R. Brown, Vanda F. Torous</dc:creator>
            <dc:date>2026-10-08</dc:date>
            <dc:title>Case 28-2026: A 19-Year-Old Woman with Fever, Cervical Lymphadenopathy, and Leukopenia</dc:title>
        </item>
        <item>
            <title>Menkes Disease</title>
            <description>A 2-month-old boy was brought to the ED after a seizure. The scalp hair was sparse and coarse. Serum copper and ceruloplasmin levels were markedly low. MR angiography showed tortuosity of the intracranial and extracranial arteries.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2607595?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2607595</guid>
            <dc:creator>Hsin-Yu Chen, Chi-Nien Chen</dc:creator>
            <dc:date>2026-10-08</dc:date>
            <dc:title>Menkes Disease</dc:title>
        </item>
        <item>
            <title>Pediatric Heart Transplantation with Donation after Circulatory Death</title>
            <description>In five pediatric heart transplantations, a rapid-recovery technique involving oxygenated preservation enabled the use of donated hearts without reanimation. All recipients had normal biventricular function by day 7.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMc2607437?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMc2607437</guid>
            <dc:creator>Aaron M. Williams, Swaroop Bommareddi, Kevin C. McGann, Awab Ahmad, John Trahanas, Brian Lima, Tammy Ruth, David W. Bearl, Rachel E. Harris, Ryan D. Byrne, Caroline West, A. Joey Lepore, Phyllis Aycock, Nicole Michaud, Sonya Burrell, Susana A. Stripling, Amir T. Dereshgi, Garrett Coyan, David Bichell, Amanpreet Kalsi, Amy M. Babb, Michael Kuntz, Jessica Clark, Shelley Scholl, Matthew Bacchetta, Ashish S. Shah, Yishay Orr, Carlos M. Mery, Ziv Beckerman</dc:creator>
            <dc:date>2026-10-08</dc:date>
            <dc:title>Pediatric Heart Transplantation with Donation after Circulatory Death</dc:title>
        </item>
        <item>
            <title>Vaping for Crypto — Smart Devices, Risky Business</title>
            <description>Recently launched smart vaping devices provide financial incentives tethered to use or engagement metrics. The addictive potential of such devices poses public health concerns.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMp2606580?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMp2606580</guid>
            <dc:creator>Amanda M. Palmer, Tracy T. Smith, Benjamin A. Toll</dc:creator>
            <dc:date>2026-10-01</dc:date>
            <dc:title>Vaping for Crypto — Smart Devices, Risky Business</dc:title>
        </item>
        <item>
            <title>Thyroglossal Duct Cyst</title>
            <description>A 6-year-old boy presented with an asymptomatic lump on the neck. Physical examination showed a nontender, midline mass in the anterior neck; ultrasonography showed a well-defined, hypoechoic mass and normal thyroid gland.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMicm2607953?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMicm2607953</guid>
            <dc:creator>Donglai Hu, Junjie Chen</dc:creator>
            <dc:date>2026-10-01</dc:date>
            <dc:title>Thyroglossal Duct Cyst</dc:title>
        </item>
        <item>
            <title>Etuvetidigene Autotemcel for the Treatment of Wiskott–Aldrich Syndrome</title>
            <description>Persons with Wiskott–Aldrich syndrome were treated with an autologous gene therapy consisting of hematopoietic stem and progenitor cells transduced ex vivo with a lentiviral vector encoding WAS complementary DNA.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMoa2515005?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMoa2515005</guid>
            <dc:creator>Francesca Ferrua, Sabina Cenciarelli, Stefania Giannelli, Stefania Galimberti, Shanmuganathan Chandrakasan, Federico Fraschetta, Carmen Caputo, Davide Sala, Ilaria Monti, Federica Barzaghi, Valeria Calbi, Daniele Canarutto, Giulia Consiglieri, Matteo Doglio, Francesca Fumagalli, Vera Gallo, Maddalena Migliavacca, Salvatore Recupero, Francesca Tucci, Alessia Orsini, Raffaella Milani, Mariam Datukishvili, Simona De Gregori, Eugenio Montini, Paolo Silvani, Matias Soncini, Elena Tomasetto, Koen van Rossem, Laura Castagnaro, Federica Miotto, Stefano Zancan, Celeste Scotti, Sean Russell, Luigi Naldini, Fabio Ciceri, Maria Ester Bernardo, Suhag Parikh, Maria Pia Cicalese, Alessandro Aiuti, the WAS Gene Therapy Group*</dc:creator>
            <dc:date>2026-09-24</dc:date>
            <dc:title>Etuvetidigene Autotemcel for the Treatment of Wiskott–Aldrich Syndrome</dc:title>
        </item>
        <item>
            <title>Case 27-2026: A 4-Year-Old Boy with Fatigue, Imbalance, and Frequent Falls</title>
            <description>A 4-year-old boy presented with fatigue and frequent falls. After falling, he could not stand up using his legs and would instead push himself up with his hands. The aminotransferase levels were elevated. A diagnosis was made.</description>
            <link>https://www.nejm.org/doi/full/10.1056/NEJMcpc2603181?rss=searchAndBrowse</link>
            <guid isPermaLink="false">https://www.nejm.org/doi/full/10.1056/NEJMcpc2603181</guid>
            <dc:creator>Alexy D. Arauz Boudreau, Hee Mang Yoon, Brenda L. Wong</dc:creator>
            <dc:date>2026-09-24</dc:date>
            <dc:title>Case 27-2026: A 4-Year-Old Boy with Fatigue, Imbalance, and Frequent Falls</dc:title>
        </item>
    </channel>
</rss>